Can a new antibiotic outperform standard care for pneumonia?
Disease control
Completed
This trial compares the antibiotic faropenem to a standard combination of co-amoxiclav and clarithromycin in adults with community-acquired bacterial pneumonia. Participants are randomly assigned to one of two treatment groups for seven days, then followed for four weeks. The stu…
Phase: PHASE4 • Sponsor: Dr. Md. Alimur Reza • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC